10 April 2026 The 2026 panel has been chosen. With judges from Amgen, Pfizer, Eli Lilly, Takeda, Regeneron and law firms such ...
New report finds that just 13% of IP-owning firms have sought financing through their assets, with billions in potential ...
The firm has added two partners to its government and regulatory team, bringing expertise in FDA matters, product approvals, ...
In light of Emotional Perception AI, the UKIPO has rewritten the rules for “mixed inventions". Matt Jefferies and Eric McNeil ...
The acquisition of Munich-based biotech gives Gilead ownership of proprietary ADCs tech at a time when pharma and biotech ...
The panel has been chosen. With judges from Amgen, Pfizer, Eli Lilly, Takeda, Regeneron and law firms such as White & Case and Arnold & Porter, here’s who will be deciding this year’s winners.
According to the settlement, MSN can maintain its challenge to several Bausch patents, while the details around potential ...
On World Health Day 2026, despite data trending in the right direction, systemic barriers continue to limit female inventors—and women's health is suffering. Already registered?
A Lisbon judge rejects a bid to strike out the case over a drafting issue, offering insight into the court’s high bar for ...
After years of strict patent rules, Argentina is changing course. New IP reforms are putting the country back on the map, but ...
Two of Europe’s most important IP offices have implemented fee increases this month, with some long-standing UK charges, ...
Despite efforts to harmonise, the Unified Patent Court’s local divisions and Court of Appeal have signalled a divergence over implementing the European Patent Convention—but does it matter? Chris ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results